Marina Kurian, MD
Surgery · New York, NYNPI 1598824971
Payments from drug & device makers
Across 457 payments — averaging $717.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$130K
- Medtronic$62K
- W. L. Gore & Associates, Inc.$35K
- AbbVie$24K
- Covidien LP$21K
- Vivus LLC$18K
- plus $39K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 108 | $130,192 |
| Medtronic | 135 | $61,749 |
| W. L. Gore & Associates, Inc. | 40 | $34,862 |
| AbbVie | 2 | $23,791 |
| Covidien LP | 30 | $20,558 |
| Vivus LLC | 19 | $17,870 |
| Stryker | 11 | $17,033 |
| Johnson & Johnson | 9 | $10,349 |
| Medical Device Business Services, Inc. | 10 | $3,985 |
| Heron Therapeutics, Inc. | 3 | $2,326 |
| Apollo Endosurgery US Inc | 4 | $1,191 |
| Reshape Lifesciences Inc. | 11 | $1,138 |
| Intuitive Surgical | 10 | $796 |
| Intra-sana Laboratories | 8 | $419 |
| Lilly USA, LLC | 17 | $298 |
| Currax Pharmaceuticals LLC | 15 | $224 |
| Merz North America, Inc. | 3 | $151 |
| Davol Inc. | 1 | $139 |
| Levita Magnetics International Corp | 2 | $133 |
| Integra Lifesciences Corporation | 1 | $129 |
| Aesculap, Inc. | 1 | $128 |
| Pfizer | 1 | $125 |
| TELA Bio, Inc. | 1 | $121 |
| Teleflex LLC | 3 | $66 |
| Endo Pharmaceuticals Inc. | 3 | $57 |
| Ambu Inc. | 1 | $56 |
| Olympus America Inc. | 1 | $45 |
| Eisai Inc. | 3 | $43 |
| Nalpropion Pharmaceuticals LLC | 2 | $32 |
| Shire North American Group Inc | 1 | $20 |
| Innocoll Pharmaceuticals Limited | 1 | $14 |
How this compares
$328,039 in reported general payments places this provider in the 95th percentile of 1,596 surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgery in New York
- Vinod BalachandranNew York$3M
- Stephanie GoffNew York$2.7M
- Alice WeiNew York$2.3M
- Cheguevara AfanehNew York$1.4M
- Flavio Malcher Martins de OliveiraNew York$814K
- Bonnie LonzeNew York$650K
- Yuri NovitskyNew York$548K
- Rasa ZarnegarNew York$478K
- Tanuja DamaniNew York$459K
- Jatin ShahNew York$451K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.